Opportunities Preloader

Please Wait.....

Report

Middle East & Africa Veterinary Pain Management Market - Industry Trends and Forecast to 2033

Market Report I 2023-09-01 I 238 Pages I Data Bridge Market Research

The Middle East and Africa veterinary pain management market is expected to reach USD 295,133.08 thousand by 2030 from USD 216,185.95 thousand in 2022 growing at a CAGR of 4.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation
Middle East and Africa Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (South Africa, Saudi Arabi, U.A.E., Egypt, Israel, Kuwait, Oman, Qatar, Bahrain, and rest Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Veterinary Pain Management Market Dynamics

- Rising incidences of pet diseases

Restraint

- High costs of pet care


Opportunity

- Technological advancements for pain management

Market Players

Some of the major market players operating in the Middle East and Africa veterinary pain management market are:

- Dechra Pharmaceuticals PLC
- Virbac
- Norbrook
- Bimeda, Inc.
- Inovet ( A subsidiary of Orion Group)
- Chanelle Pharma
- Vetoquinol
- Elanco
- Merck & Co., Inc.
- Ceva Animal Health, LLC


TABLE OF CONTENTS
1 INTRODUCTION 60
1.1 OBJECTIVES OF THE STUDY 60
1.2 MARKET DEFINITION 60
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET 60
1.4 CURRENCY AND PRICING 62
1.5 LIMITATIONS 62
1.6 MARKETS COVERED 63
2 MARKET SEGMENTATION 66
2.1 MARKETS COVERED 66
2.2 GEOGRAPHICAL SCOPE 67
2.3 YEARS CONSIDERED FOR THE STUDY 68
2.4 DBMR TRIPOD DATA VALIDATION MODEL 69
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 72
2.6 MULTIVARIATE MODELLING 73
2.7 MARKET END USER COVERAGE GRID 73
2.8 PRODUCT LIFELINE CURVE 74
2.9 DBMR MARKET POSITION GRID 75
2.10 VENDOR SHARE ANALYSIS 76
2.11 SECONDARY SOURCES 77
2.12 ASSUMPTIONS 77
3 EXECUTIVE SUMMARY 78
4 PREMIUM INSIGHTS 81
4.1 PESTEL ANALYSIS 82
4.2 PORTER'S FIVE FORCES 83
4.3 BRAND REVENUE ANALYSIS 84
5 MARKET OVERVIEW 85
5.1 DRIVERS 87
5.1.1 INCREASING PET OWNERSHIP 87
5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 87
5.1.3 GROWING INCIDENCES OF PET DISEASES 88
5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 88
5.2 RESTRAINTS 89
5.2.1 INCREASING PET CARE COSTS 89
5.2.2 STRICT REGULATORY GUIDELINES 89?
5.3 OPPORTUNITIES 90
5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 90
5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 91
5.3.3 TECHNOLOGICAL ADVANCEMENTS 91
5.4 CHALLENGES 92
5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 92
5.4.2 RESISTANCE TO MEDICATIONS 92
6 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 93
6.1 OVERVIEW 94
6.2 ANALGESICS 95
6.2.1 ANTI- INFLAMMATORY (NSAIDS) 96
6.2.1.1 CARPROFEN 96
6.2.1.2 MELOXICAM 96
6.2.1.3 PHENYLBUTAZONE 96
6.2.1.4 ACETAMINOPHEN 96
6.2.1.5 FIROCOXIB 96
6.2.1.6 DERACOXIB 97
6.2.1.7 OTHERS 97
6.2.2 OPIOIDS 97
6.2.2.1 MU AGONISTS 97
6.2.2.1.1 METHADONE 99
6.2.2.1.2 MEPERIDINE 99
6.2.2.1.3 MORPHINE 99
6.2.2.1.4 OXYMORPHONE 99
6.2.2.1.5 OTHERS 99
6.2.2.2 PARTIAL MU AGONIST 99
6.2.2.2.1 BUPRENORPHINE 99
6.2.2.2.2 OTHERS 100
6.2.2.3 KAPPA AGONIST MU ANTAGONIST 100
6.2.2.3.1 BUTORPHANOL 100
6.2.2.3.2 OTHERS 100
6.3 CORTICOSTEROIDS 101
6.3.1 DEXAMETHASONE 101
6.3.2 PREDNISOLONE 101
6.3.3 PREDNISONE 101
6.3.4 OTHERS 102
6.4 ALPHA 2 AGONISTS 102
7 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 103
7.1 OVERVIEW 104
7.2 BRANDED 105
7.3 GENERIC 105
8 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 107
8.1 OVERVIEW 108
8.2 PRESCRIPTION BASED 109
8.3 OTC 109
9 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 111
9.1 OVERVIEW 112
9.2 COMPANION ANIMAL 113
9.2.1 CANINE 114
9.2.2 EQUINE 114
9.2.3 FELINE 114
9.2.4 OTHERS 114
9.3 PRODUCTION ANIMAL 114
9.3.1 CATTLE 115
9.3.2 SWINE 115
9.3.3 POULTRY 115
9.3.4 FISH 115
9.3.5 OTHERS 115
10 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 116
10.1 OVERVIEW 117
10.2 CHRONIC PAIN 118
10.3 ACUTE PAIN 119
10.4 POST OPERATIVE PAIN 119
10.5 DENTAL PAIN 120?
11 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 121
11.1 OVERVIEW 122
11.2 SOLID 123
11.2.1 TABLET 124
11.2.2 POWDER 124
11.2.3 OTHERS 124
11.3 LIQUID 124
11.3.1 SOLUTION 125
11.3.2 SYRUP 125
11.3.3 SUSPENSION 125
11.3.4 OTHERS 125
11.4 SEMI SOLID 125
11.4.1 GEL 126
11.4.2 CREAM 126
11.4.3 OTHERS 126
12 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 127
12.1 OVERVIEW 128
12.2 PARENTERAL 129
12.3 ORAL 130
12.4 TOPICAL 130
13 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER 131
13.1 OVERVIEW 132
13.2 VETERINARY HOSPITALS 133
13.3 VETERINARY CLINICS 134
13.4 PET SHOPS 134
13.5 ANIMAL FARMS 135
13.6 ACADEMIC & RESEARCH INSTITUTES 135
13.7 OTHERS 136?
14 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 137
14.1 MIDDLE EAST AND AFRICA 138
14.1.1 SOUTH AFRICA 146
14.1.2 SAUDI ARABIA 153
14.1.3 U.A.E. 160
14.1.4 EGYPT 167
14.1.5 ISRAEL 174
14.1.6 KUWAIT 181
14.1.7 OMAN 188
14.1.8 QATAR 195
14.1.9 BAHRAIN 202
14.1.10 REST OF MIDDLE EAST AND AFRICA 209
15 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 210
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 210
16 SWOT ANALYSIS 211
17 COMPANY PROFILE 212
17.1 ZOETIS SERVICES LLC 212
17.1.1 COMPANY SNAPSHOT 212
17.1.2 COMPANY SHARE ANALYSIS 212
17.1.3 PRODUCT PORTFOLIO 213
17.1.4 RECENT DEVELOPMENTS 213
17.2 ELANCO 214
17.2.1 COMPANY SNAPSHOT 214
17.2.2 REVENUE ANALYSIS 214
17.2.3 COMPANY SHARE ANALYSIS 215
17.2.4 PRODUCT PORTFOLIO 215
17.2.5 RECENT DEVELOPMENT 215
17.3 MERCK & CO., INC. 216
17.3.1 COMPANY SNAPSHOT 216
17.3.2 REVENUE ANALYSIS 216
17.3.3 COMPANY SHARE ANALYSIS 217
17.3.4 PRODUCT PORTFOLIO 217
17.3.5 RECENT DEVELOPMENT 217?
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 218
17.4.1 COMPANY SNAPSHOT 218
17.4.2 COMPANY SHARE ANALYSIS 218
17.4.3 PRODUCT PORTFOLIO 219
17.4.4 RECENT DEVELOPMENT 219
17.5 VETOQUINOL 220
17.5.1 COMPANY SNAPSHOT 220
17.5.2 REVENUE ANALYSIS 220
17.5.3 COMPANY SHARE ANALYSIS 221
17.5.4 PRODUCT PORTFOLIO 221
17.5.5 RECENT DEVELOPMENTS 221
17.6 BIMEDA, INC. 223
17.6.1 COMPANY SNAPSHOT 223
17.6.2 PRODUCT PORTFOLIO 223
17.6.3 RECENT DEVELOPMENT 223
17.7 CEVA ANIMAL HEALTH, LLC 224
17.7.1 COMPANY SNAPSHOT 224
17.7.2 PRODUCT PORTFOLIO 224
17.7.3 RECENT DEVELOPMENT 224
17.8 CHANELLE PHARMA 225
17.8.1 COMPANY SNAPSHOT 225
17.8.2 PRODUCT PORTFOLIO 225
17.8.3 RECENT DEVELOPMENT 225
17.9 DECHRA PHARMACEUTICALS PLC 226
17.9.1 COMPANY SNAPSHOT 226
17.9.2 REVENUE ANALYSIS 226
17.9.3 PRODUCT PORTFOLIO 227
17.9.4 RECENT DEVELOPMENTS 227
17.10 DURVET ANIMAL HEALTH PRODUCTS 228
17.10.1 COMPANY SNAPSHOT 228
17.10.2 PRODUCT PORTFOLIO 228
17.10.3 RECENT DEVELOPMENT 228
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 229
17.11.1 COMPANY SNAPSHOT 229
17.11.2 PRODUCT PORTFOLIO 229
17.11.3 RECENT DEVELOPMENTS 229?
17.12 NORBROOK 231
17.12.1 COMPANY SNAPSHOT 231
17.12.2 PRODUCT PORTFOLIO 231
17.12.3 RECENT DEVELOPMENT 231
17.13 VIRBAC 232
17.13.1 COMPANY SNAPSHOT 232
17.13.2 REVENUE ANALYSIS 232
17.13.3 PRODUCT PORTFOLIO 233
17.13.4 RECENT DEVELOPMENT 233
18 QUESTIONNAIRE 234
19 RELATED REPORTS 238

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE